Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug.
about
Simultaneous quantification of proposed anti-malarial combination comprising of lumefantrine and CDRI 97-78 in rat plasma using the HPLC-ESI-MS/MS method: application to drug interaction study.Drugs in Development for Malaria.Recent updates in the discovery and development of novel antimalarial drug candidates
P2860
Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-in-Human Study of a Novel Antimalarial Drug.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@en
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@nl
type
label
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@en
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@nl
prefLabel
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@en
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@nl
P2093
P2860
P356
P1476
Single Ascending Dose Safety a ...... of a Novel Antimalarial Drug.
@en
P2093
H N Kushwaha
J S Srivastava
N Chandurkar
S Achuthan
P2860
P304
P356
10.1155/2014/372521
P577
2014-03-27T00:00:00Z